Y-Intercept (HK)’s Oruka Therapeutics ORKA Stock Holding History

Y-Intercept (HK)’s Portfolio ORKA Stock Details ORKA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-36,912	Closed	-$1.81M	–	2256
2026 Q1	$1.81M	Buy	+36,912	New	+$1.28M	0.03%	763

Other funds holding ORKA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Y-Intercept (HK)'s ORKA Position: Q2 2026 in Review

Y-Intercept (HK) sold out of Oruka Therapeutics (ORKA) in Q2 2026, closing a stake of 36,912 shares — an estimated $1.81M sold.

Y-Intercept (HK) first reported a position in ORKA in Q1 2026 and held it in 1 quarter. The position peaked at $1.81M in Q1 2026. 256 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

Y-Intercept (HK) reported no remaining Oruka Therapeutics position as of Q2 2026 after selling out during the quarter.
Y-Intercept (HK) sold 36,912 Oruka Therapeutics shares in Q2 2026, an estimated $1.81M.
Y-Intercept (HK) first reported a position in Oruka Therapeutics in Q1 2026 and held it in 1 quarter.
Y-Intercept (HK)'s Oruka Therapeutics position peaked at $1.81M in Q1 2026.
256 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.